2023 Cannabis CBD Pets 
Cannabis Law Report
SEPTEMBER 21, 2022
Idaho State Department of Agriculture’s plan to ban animal health supplements containing hemp and CBD have some pet owners and businesses claiming it’s a very ruff deal. Pet business Bark n’ Purr Boise is among those vigorously opposing the ban. At the time of writing, the petition had attracted 784 signatures.
The Blunt Truth
FEBRUARY 24, 2023
On the federal level, we have an update on the VA Medical Cannabis Act – will it become part of the SAFE Plus Act? And finally, Rhode Island may allow Fido or Fluffy to get a CBD prescription. The devil is in the details when it comes to forming a system to sell cannabis, and progress has been slow. The bill’s sponsor, Sen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 9, 2019
Cannabidiol, known as CBD by most consumers, has taken center stage as the supplement of the decade. In fact, the Brightfield Group claims that the CBD market may reach $24 billion by 2023, good news for businesses such as Next Green Wave, Inc. What makes CBD so special? CBD for Pets – a revolutionary health aid?
Cannabis Law Report
JANUARY 30, 2023
After more than four years of market expansion of foods, beverages, cosmetics and other products for human consumption, as well as pet food products, containing hemp-derived cannabidiol (CBD) since passage of the 2018 Farm Bill, 7 U.S.C. Food & Drug Administration (FDA) stated on January 26, 2023, that […]
The Joint Blog
JANUARY 12, 2020
The market for CBD pet products has exploded in recent years, with numerous success stories. However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. Because the federal government has yet to establish standards for CBD, these companies can get away with it.
MJ Business Attorneys
JULY 29, 2019
market for CBD continues to skyrocket and companies competing in the cannabis space become more developed, they are being held back by the slow federal regulatory response at the Food and Drug Administration. ” Curaleaf is the first multistate CBD company to receive such a notice from the FDA. CBD sales by 2023.
The Joint Blog
JANUARY 28, 2020
“You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” Cornell University veterinary researcher Joseph Wakshlag, who studies therapeutic uses for the compound, told the Associated Press. “Or billion by 2023, according to the cannabis research firm Brightfield Group.”
Expert insights. Personalized for you.
52 
Let's personalize your content